Pacira BioSciences, Inc.
PCRX
$25.32
$0.8653.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 493.63M | 484.62M | 453.81M | 404.23M | 325.89M |
| Total Receivables | 105.15M | 113.80M | 100.95M | 104.78M | 101.74M |
| Inventory | 133.75M | 125.28M | 111.87M | 103.44M | 96.78M |
| Prepaid Expenses | 27.44M | 20.43M | 23.34M | 19.77M | 18.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 1.00M | -- | -- | -- |
| Total Current Assets | 759.96M | 745.13M | 689.97M | 632.21M | 543.11M |
|
|
|||||
| Total Current Assets | 759.96M | 745.13M | 689.97M | 632.21M | 543.11M |
| Net Property, Plant & Equipment | 213.18M | 216.39M | 220.68M | 225.11M | 230.43M |
| Long-term Investments | 21.52M | -- | -- | 163.24M | 163.24M |
| Goodwill | 21.52M | -- | -- | 163.24M | 163.24M |
| Total Other Intangibles | 434.97M | 425.97M | 440.29M | 454.61M | 468.94M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 129.01M | 136.58M | 134.02M | 135.14M | 141.06M |
| Total Assets | 1.59B | 1.55B | 1.52B | 1.65B | 1.58B |
|
|
|||||
| Total Accounts Payable | 23.17M | 19.13M | 19.37M | 18.73M | 8.98M |
| Total Accrued Expenses | 80.07M | 69.52M | 76.38M | 64.81M | 66.82M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 211.49M | 210.66M | 210.66M | 9.15M | 17.64M |
| Total Finance Division Other Current Liabilities | -- | 10.61M | -- | -- | -- |
| Total Other Current Liabilities | -- | 10.61M | -- | -- | -- |
| Total Current Liabilities | 314.73M | 309.92M | 306.40M | 92.69M | 93.44M |
|
|
|||||
| Total Current Liabilities | 314.73M | 309.92M | 306.40M | 92.69M | 93.44M |
| Long-Term Debt | 381.29M | 383.55M | 385.89M | 589.30M | 511.69M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 43.68M | 44.65M | 47.88M | 50.15M | 52.45M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 48.43M | 37.06M | 31.94M | 35.41M | 33.58M |
| Total Liabilities | 788.13M | 775.17M | 772.11M | 767.54M | 691.16M |
|
|
|||||
| Common Stock & APIC | 1.02B | 1.01B | 996.42M | 983.23M | 989.83M |
| Retained Earnings | -201.54M | -206.36M | -222.40M | -78.93M | -97.82M |
| Treasury Stock & Other | -23.77M | -24.78M | -24.44M | -25.02M | 152.00K |
| Total Common Equity | 798.54M | 778.35M | 749.58M | 879.28M | 892.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 798.54M | 778.35M | 749.58M | 879.28M | 892.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 798.54M | 778.35M | 749.58M | 879.28M | 892.16M |
|
|
|||||